Crescent Energy Company (CRGY) Financial Statements
Crescent Energy Company (CRGY) reported trailing twelve-month revenue of $4.3B (up 24.3% year on year) and net income of $54.8M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $833.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 4.6B
- P/E TTM
- 93.3
- Dividend yield
- 3.1%
- 52-week
- —
- Next earnings
- 2 Nov, in 8 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 15 Oct; these figures move once the 10-Q is filed.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 1.48 | 3.06 | 2.38 | 2.93 | 3.58 | 4.31 | |
| Gross profit | 0.56 | 1.37 | 0.47 | 0.55 | 0.70 | 1.30 | |
| Operating income | 0.48 | 1.28 | 0.32 | 0.22 | 0.23 | 0.89 | |
| Pre-tax income | -0.43 | 0.52 | 0.35 | -0.17 | 0.20 | 0.15 | |
| Income tax | -0.00 | 0.04 | 0.02 | -0.03 | 0.03 | 0.08 | |
| Net income | -0.02 | 0.10 | 0.07 | -0.11 | 0.13 | 0.05 | |
| Diluted EPS ($) | — | — | 1.02 | -0.88 | 0.54 | 0.15 | |
| Diluted shares (bn) | — | — | 0.067 | 0.131 | 0.245 | — |
USD billions · SEC XBRL
Crescent Energy Company — questions
- What is Crescent Energy Company's revenue?
- $4.3B over the twelve months to 2026-06-30, up 24.3% year on year, from its 10-Q and 10-K filings.
- What is Crescent Energy Company's net income?
- $54.8M over the twelve months to 2026-06-30.
- What is Crescent Energy Company's free cash flow?
- $833.7M over the twelve months to 2026-06-30.
- What are Crescent Energy Company's diluted earnings per share?
- $0.15 over the twelve months to 2026-06-30.
Every figure on this page comes from Crescent Energy Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.